Serum TSH is positively associated with BMI

被引:209
作者
Nyrnes, A [1 ]
Jorde, R
Sundsfjord, J
机构
[1] Univ Hosp N Norway, Dept Geriatr Med, N-9038 Tromso, Norway
[2] Univ Tromso, Inst Clin Med, Tromso, Norway
[3] Univ Hosp N Norway, Dept Clin Chem, Tromso, Norway
关键词
body mass index; longitudinal study; smoking; thyroid-stimulating hormone; weight gain;
D O I
10.1038/sj.ijo.0803112
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To investigate whether there is an association between serum thyroid-stimulating hormone (TSH) within the normal range and body mass index (BMI). Design and subjects: The study was performed in 6164 subjects (2813 males) who attended the fifth Tromso study in 2001, and in 1867 subjects (873 males) that attended both the fourth Tromso study in 1994/1995 as well as the fifth Tromso study. Measurements: Height, weight, and serum TSH were measured in all subjects, and smoking status was recorded. Results: Smokers and nonsmokers were analyzed separately. In the fifth Tromso study, serum TSH was positively and significantly associated with BMI in the nonsmokers. Within the normal TSH range (defined as the 2.5-97.5 percentile), nonsmoking males in the highest TSH quartile had a mean BMI 0.4 kg/m(2) higher compared to those in the lower quartile, whereas the difference for nonsmoking women was 1.4 kg/m(2). Similarly, in nonsmokers in the longitudinal study, there was a significant and positive association between delta serum TSH (serum TSH in 2001 minus serum TSH in 1994) and delta BMI in those with serum TSH within the normal range both in 1994 and 2001. In these subjects, the quartile with the highest delta serum TSH had a mean increase in BMI from 1994 to 2001 that was 0.3 kg/m(2) higher compared to those in the quartile with the lowest delta serum TSH. For the smokers, relations between serum TSH and BMI were not statistically significant. Conclusion: In nonsmokers there is a positive association between serum TSH within the normal range and BMI.
引用
收藏
页码:100 / 105
页数:6
相关论文
共 30 条
[1]   Subclinical hyperthyroidism as a risk factor for atrial fibrillation [J].
Auer, J ;
Scheibner, P ;
Mische, T ;
Langsteger, W ;
Eber, O ;
Eber, B .
AMERICAN HEART JOURNAL, 2001, 142 (05) :838-842
[2]   Leptin [J].
Auwerx, J ;
Staels, B .
LANCET, 1998, 351 (9104) :737-742
[3]  
BARON DN, 1956, LANCET, V271, P277
[4]   Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population.: The Health Study of Nord-Trondelag (HUNT) [J].
Bjoro, T ;
Holmen, J ;
Krüger, O ;
Midthjell, K ;
Hunstad, K ;
Schreiner, T ;
Sandnes, L ;
Brochmann, H .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (05) :639-647
[5]   The Colorado thyroid disease prevalence study [J].
Canaris, GJ ;
Manowitz, NR ;
Mayor, G ;
Ridgway, EC .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (04) :526-534
[6]   INFLUENCE OF CIGARETTE-SMOKING ON GOITER FORMATION, THYROGLOBULIN, AND THYROID-HORMONE LEVELS IN WOMEN [J].
CHRISTENSEN, SB ;
ERICSSON, UB ;
JANZON, L ;
TIBBLIN, S ;
MELANDER, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 58 (04) :615-618
[7]   The treatment of subclinical hypothyroidism is seldom necessary [J].
Chu, JW ;
Crapo, LM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) :4591-4599
[8]   Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: A quantitative review of the literature [J].
Danese, ND ;
Ladenson, PW ;
Meinert, CL ;
Powe, NR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) :2993-3001
[9]   ENZYME-ACTIVITIES RELATED TO FATTY-ACID SYNTHESIS IN LIVER AND ADIPOSE-TISSUE OF RATS TREATED WITH TRIIODOTHYRONINE [J].
DIAMANT, S ;
SHAFRIR, E ;
GORIN, E .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1972, 26 (04) :553-&
[10]   Thyroid disease and lipids [J].
Duntas, LH .
THYROID, 2002, 12 (04) :287-293